Brandi Robinson
Plus aucun poste en cours
Profil
Brandi Robinson is a former Director-Investor Relations at Novartis AG.
She also held the position of Senior Vice President-Communications at Seagen Inc. from 2016 to 2018.
Prior to that, she was Vice President & Head-Communications at Novartis Corp.
from 2009 to 2012.
Ms. Robinson has also worked as the Chief Communications Officer at Mallinckrodt Plc and as a Principal at Ciba Vision Corp.
and Novartis Pharmaceuticals Corp.
She served as the Chief Communications Officer & Senior VP at Mallinckrodt Pharmaceuticals Ltd.
Ms. Robinson's most recent position was as the Chief Corporate Affairs Officer at Rafael Holdings, Inc. from 2021 to 2022.
Currently, she is the Senior Vice President-Corporate Affairs at Avadel Pharmaceuticals Plc.
Ms. Robinson completed her undergraduate degree at Fairleigh Dickinson University.
Anciens postes connus de Brandi Robinson
| Sociétés | Poste | Fin |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/05/2023 |
| RAFAEL HOLDINGS, INC. | Corporate Officer/Principal | 31/01/2022 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 11/11/2021 |
| SEAGEN INC. | Public Communications Contact | 01/02/2018 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Public Communications Contact | 01/11/2012 |
Formation de Brandi Robinson
| Fairleigh Dickinson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| RAFAEL HOLDINGS, INC. | Finance |
| Entreprise privées | 5 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Ciba Vision Corp.
 Ciba Vision Corp. Electronic ComponentsElectronic Technology CIBA VISION Corp. manufactures eyeglasses, contact lenses and lens care products. It offers research, development, manufacturing contact lenses and lens care products. The company was founded in 1980 and is headquartered in Duluth, GA. | Electronic Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
